Figure 4.
Mortality rates from HL in 500 patients at CS IA and IIA. Groups A+B included 42 patients with LPHL plus 144 patients with cHL without MI; group C comprised 314 patients with cHL with MI (P log-rank A+B versus C = .04).
Mortality rates from HL in 500 patients at CS IA and IIA. Groups A+B included 42 patients with LPHL plus 144 patients with cHL without MI; group C comprised 314 patients with cHL with MI (P log-rank A+B versus C = .04).
